A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario

Cancer immunotherapy: the beginning of the end of cancer?

(2016) Sofia Farkona et al.   BMC Medicine

Immunotherapy and tumor microenvironment

(2016) Haidong Tang et al.   CANCER LETTERS

Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma

(2016) Morton Coleman et al.   Clinical Lymphoma Myeloma & Leukemia

Studying cancer metastasis: Existing models, challenges and future perspectives

(2016) Denise M.S. van Marion et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks

(2015) F Guo et al.   ONCOGENE

PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis

(2015) Silvana Novelli et al.   Advances in Clinical and Experimental Medicine

The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies

(2015) Leisha A. Emens et al.   Cancer Immunology Research

Evaluation of the specificity of [18F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [18F]FDG and impact of rituximab therapy

(2015) Narinée Hovhannisyan et al.   EJNMMI Research

Lymphoma Immunotherapy: Current Status

(2015) Roberta Zappasodi et al.   Frontiers in Immunology

Cancer metastases: challenges and opportunities

(2015) Xiangming Guan   Acta Pharmaceutica Sinica B

Current role of FDG PET/CT in lymphoma

(2014) Lale Kostakoglu et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Salmonella entericaserovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect

(2014) Sofía Grille et al.   IMMUNOLOGY

Chemoimmunotherapy: reengineering tumor immunity

(2013) Gang Chen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A therapeutic vaccine using Salmonella-modified tumor cells combined with interleukin-2 induces enhanced antitumor immunity in B-cell lymphoma

(2012) Sofía Grille et al.   LEUKEMIA RESEARCH

12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

(2012) Jane L. Messina et al.   Scientific Reports

Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling

(2011) Domenico Coppola et al.   AMERICAN JOURNAL OF PATHOLOGY

Translational development of vaccination strategies in follicular NHL

(2011) Ippei Sakamaki et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma

(2011) Stephen J. Schuster et al.   JOURNAL OF CLINICAL ONCOLOGY

Translational research: 4 ways to fix the clinical trial

(2011) Heidi Ledford   NATURE

Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP

(2010) John F. DiJoseph et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells

(2009) Sofía Grille et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

(2009) H. Harlin et al.   CANCER RESEARCH